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Abstract
Background: Over 60% of protein-coding genes in vertebrates express mRNAs that undergo
alternative splicing. The resulting collection of transcript isoforms poses significant challenges for
contemporary biological assays. For example, RT-PCR validation of gene expression microarray
results may be unsuccessful if the two technologies target different splice variants. Effective use of
sequence-based technologies requires knowledge of the specific splice variant(s) that are targeted.
In addition, the critical roles of alternative splice forms in biological function and in disease suggest
that assay results may be more informative if analyzed in the context of the targeted splice variant.
Results: A number of contemporary technologies are used for analyzing transcripts or proteins.
To enable investigation of the impact of splice variation on the interpretation of data derived from
those technologies, we have developed SpliceCenter. SpliceCenter is a suite of user-friendly, web-
based applications that includes programs for analysis of RT-PCR primer/probe sets, effectors of
RNAi, microarrays, and protein-targeting technologies. Both interactive and high-throughput
implementations of the tools are provided. The interactive versions of SpliceCenter tools provide
visualizations of a gene's alternative transcripts and probe target positions, enabling the user to
identify which splice variants are or are not targeted. The high-throughput batch versions accept
user query files and provide results in tabular form. When, for example, we used SpliceCenter's
batch siRNA-Check to process the Cancer Genome Anatomy Project's large-scale shRNA library,
we found that only 59% of the 50,766 shRNAs in the library target all known splice variants of the
target gene, 32% target some but not all, and 9% do not target any currently annotated transcript.
Conclusion: SpliceCenter http://discover.nci.nih.gov/splicecenter provides unique, user-friendly
applications for assessing the impact of transcript variation on the design and interpretation of RT-
PCR, RNAi, gene expression microarrays, antibody-based detection, and mass spectrometry
proteomics. The tools are intended for use by bench biologists as well as bioinformaticists.
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Background
Technologies commonly used by biologists to investigate
gene function include quantitative RT-PCR (qRT-PCR)
assays, RNA interference (RNAi) mediated by small inter-
fering RNAs (siRNAs) or short hairpin RNAs (shRNAs),
gene expression microarrays, and antibody-based protein
assays. Each of those technologies targets a small nucleic
or amino acid sequence that, preferably, is unique to a
specific gene.
More than 60% of protein-coding genes in vertebrates
exhibit splice variation [1,2]. Alternative splicing compli-
cates the selection of target sequence and interpretation of
resulting data. In many cases, the targeted sequence might
not be present in all of a gene's transcript forms. The prev-
alence of alternative spliceforms suggests many questions
that routinely confront biologists who use oligonucle-
otide- or peptide-based assays. For example:
• Which specific splice variants are targeted by my assay?
What other splice variants exist?
￿ Do the RT-PCR primers/probes that I plan to use to val-
idate microarray expression results target the same splice
variants as were targeted by the microarray platform?
￿ Did an siRNA fail to mediate RNAi silencing of a gene
because it did not target the dominant splice isoform?
￿ Is there known splice variation in my gene of interest
that affects the protein coding portion of the transcript?
Does the antibody that I plan to use target all potential
protein products?
￿ Where could I place RT PCR primers to target all splice
variants? Where could I place RT PCR primers to amplify
one specific splice variant to the exclusion of others?
￿ Do expression values from one microarray fail to corre-
late with values from another microarray because the
probesets target different splice variants?
Questions such as those are not motivated by a particular
research focus on alternative splicing, but rather by the
need to account for the impact of splice variation in
almost every high-throughput biological study. In our lab-
oratories, for example, we have experienced several such
issues, including an siRNA that failed to target the domi-
nant transcript in a particular cell line and RT PCR results
that failed to correlate with microarray expression data
because different splice forms were targeted [3].
In addition to the pragmatic motivations for evaluating
the splice variants targeted by a given assay, there may also
be scientific benefit. Alternate splice forms have been
associated with tissue-specific gene functions, develop-
mental processes, and disease states (notably cancer)
[4,5]. Genes with splice variation in the coding region
produce different proteins with potentially dramatically
different functions. For example, the Epidermal Growth
Factor Receptor (EGFr), a major target for cancer therapy,
can be expressed in the transmembrane receptor form or
as a soluble isoform that competes with the receptor for
binding of ligand. Transcripts with variation in the
untranslated regions (UTRs) may be differentially regu-
lated and therefore exhibit differences in spatial or tempo-
ral expression patterns.
Several publicly-accessible websites provide data and util-
ities for investigating alternative splicing: AceView [6],
Alternative Splicing Annotation Project database (ASAP
II) [7], Alternative Splicing and Transcript Diversity Data-
base (ATSD) [8], Friendly Alternative Splicing and Tran-
script Database (fastdb2) [9], Hollywood [10], Eukaryotic
Splice Database (EUSplice) [11], and Genome Annota-
tion for Alternative Splicing (ECgene) [12], and Splicy
[13]. Each of those databases provides information on
transcript variants and in some cases additional annota-
tion, including splicing regulatory elements, exon charac-
teristics (e.g. alternative, constitutive, retained, internal),
and EST evidence/tissue of origin data. Although some of
those programs are excellent resources for alternative
splicing data, none of them provide query features and
output focused on, and tuned to, the need of bench biol-
ogists to understand the impact of alternative splicing on
their sequence-based or hybridization-based assays. A
comparison of SpliceCenter with the other available
resources is summarized in Table 1.
To meet the needs of biologists as well as bioinformati-
cists, we have developed SpliceCenter, a comprehensive,
rapid, user-friendly suite of web-based tools for identify-
ing the alternative transcripts targeted by contemporary
technologies. The SpliceCenter tools include: "Primer-
Check" for evaluation of qRT-PCR primers/probes,
siRNA-Check" for analysis of RNAi effectors, "Array-
Check" for analysis of mRNA expression microarray
probes, and "Peptide-Check" for analysis of peptides (e.g.,
in antibody-based binding assays and mass spectrome-
try). SpliceCenter applications provide the novel ability to
cross-compare the technologies (e.g., with a single graph-
ical visualization that indicates both the splice forms of a
gene that are targeted by RT-PCR primers and those that
are targeted by a microarray probe set).
SpliceCenter was developed using infrastructure from our
previously described SpliceMiner application [14] includ-
ing the splice variant database structure and microarray
probe assignment features. SpliceCenter represents a sub-
stantial advance over our previous work in terms of theBMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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database content, website utilities, and breadth of poten-
tial users. The database was rebuilt and extended to
include the latest genomic and transcript data, mouse and
rat genomes, position of coding regions, identification of
NMD targets, protein sequences, and pre-computed
microarray probe targets. The new website utilities pro-
vide custom, user-friendly applications tailored to the
needs of bench biologists who are applying such technol-
ogies as RT-PCR, RNAi, microarrays, or peptide-based
assays. The focused nature of SpliceCenter utilities pro-
vide a significant time savings compared to our previous
application [see Additional file 1]. Additional query facil-
ities were also implemented to process protein sequences
and very short oligos (e.g. siRNA and PCR primer
sequences).
Construction and Content
SpliceCenter applications are web-based Java programs
(JSPs and servlets) that query two mysql databases: Evi-
dence Viewer Database (EVDB) and Microarray Database.
EVDB contains the complete coding transcripts from Ref-
Seq(release 29) and GenBank(release 165) that represent
distinct splice variants. (See reference [14,15] for details
on the contents and construction of EVDB). The Microar-
ray database contains pre-computed probe target posi-
tions for more than 11 million probes covering 32
commercial microarrays [see Additional file 1]. Figure 1
provides a high-level overview of the software architec-
ture, which follows a traditional model-view-controller
pattern.
We needed to develop new sequence-alignment compo-
nents for PCR-Check and siRNA-Check because the rela-
tively short sequence lengths (e.g., 21 nucleotide
sequences of siRNAs) were problematic for our previously
developed sequence alignment functions. The new
sequence search component makes use of the open source
PrimerMatch [16] application to align user-provided PCR
primer or siRNA sequences with transcript sequences. We
selected PrimerMatch because, unlike BLAT and BLAST, it
can rapidly and accurately align very short query
sequences.
For Peptide-Check, a peptide-to-protein alignment is per-
formed with the translated protein sequences from the
RefSeq and GenBank records in our splice variant data-
Table 1: Comparison of SpliceCenter features with those of other web-based splicing resources
SpliceCenter Capability AceView ASAP ATSD fastdb2 Hollywood EUSplice ECgene Splicy
General
Simple, Intuitive Interface ✔
Help and Sample Queries ✔✔ * * * ✔✔ *
Splice Variants
Graphical display of gene's splice variants ✔✔ ✔ ✔ ✔ ✔ ✔ ✔
Identifies coding regions ✔✔ ✔
Identifies NMD targets ✔
Human, Mouse, and Rat * ✔✔ ** ✔✔ *
PCR
Primer sequence query showing position in variants ✔✔
Batch high-throughput primer query
siRNA
siRNA sequence query showing position in variants
Batch high-throughput hit/miss report for siRNAs
Microarray
Display pre-computed target positions of Affymetrix, 
Agilent, Illumina, and ExonHit probesets in gene's 
variants
*
Display integrated graphic of microarray probe 
targets and primer target positions.
Batch high-throughput query of pre-computed probe/
probeset target positions
*
Peptide
Peptide sequence query displaying source coding 
region in splice variants
Batch high-throughput peptide query
This table shows the capabilities of SpliceCenter in the first column and identifies other splicing database websites with similar features. The 
comparison is done from the point of view of a biologist interested in investigating the impact of alternative splicing on a sequence-based assay. 
Other sites contain features not found in SpliceCenter but which are not directly applicable to the focused tasks addressed by our tools. A 
'✔'indicates presence of a feature, a blank cell indicates absence of a feature, and a '*' indicates partial implementation of a feature.BMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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A component interaction diagram of the SpliceCenter software Figure 1
A component interaction diagram of the SpliceCenter software. The processes depicted in the figure are keyed to 
the following steps: (1) The HTML Browser submits a form that contains the user query specifying a gene and a microarray, 
PCR primer sequences, siRNA sequences, and/or peptide sequences. (2) The HTML request is received by a utility-specific 
servlet that performs input validation. The servlet calls the Sequence Search class providing the primer, siRNA, or peptide 
sequence as input. (3) The Sequence Search class runs the open source sequence search tool PrimerMatch [16] to locate com-
plementary sequences within a database of unique splice variant transcripts. (3) PrimerMatch returns hits for the query 
sequences. The Sequence Search class parses the PrimerMatch results and identifies the best match. (4) Sequence Search 
Result objects are returned to the servlet. (5) Transcript coordinates for alignment of the hits are converted into genomic 
coordinates by querying EVDB. Also, the user-specified microarray and gene symbol are used to identify microarray probe 
positions for the specified gene. (6) Genomic coordinates for each query sequence are packaged into position objects. Micro-
array probe coordinates are returned in probe-position objects. (7) The user-provided gene symbol (or automatically derived 
target gene for siRNAs or peptides) is used to query all known splice variants in EVDB. (8) Gene, Variant, and Exon objects are 
returned. Those objects provide the genomic coordinates of the exons in each unique splice variant. (9) Gene objects and posi-
tion objects are forwarded in the HTML Request to the PrimerCheck Java Server Page. The JSP is responsible for presentation 
of search results. (10) The JSP calls the ImageGenerator class, which uses the gene and position objects to construct a graphical 
image of the splice variants and target positions. To create a graphical output, the ImageGenerator class uses the Java AWT 
classes, including Graphics2D. Graphical images are temporarily stored on the disk drive on the Tomcat Server. (11) An image 
tag, complete with a tooltip map, is returned to the JSP for inclusion in the results page. (12) An HTML page with the search 
results is returned to the user's browser. (13) The image tag on the results page refers to the Image Servlet with a unique ID 
of the user's result image. The browser automatically requests the image from the Image Servlet. (14) The Image Servlet deliv-
ers the PNG format image file and cleans the image file from temporary storage.
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base. Alignments are converted into chromosomal coordi-
nates, and thus into the transcript position, via  EVDB
mappings.
An overview of the strategy for determining the positions
targeted by PCR primers or siRNA/shRNAs is provided in
Figure 2. A key processing step performed by SpliceCenter
applications is conversion of various elements into a com-
mon frame of reference, genomic coordinates. The target
positions of user-supplied sequences and microarray
probes are determined by a 100% identity match to tran-
script or protein sequences in our database. Identifying
the genomic coordinate positions of splice variants,
exons, microarray probes, PCR primers, siRNAs, shRNAs
and peptides allows the creation of a graphical image that
displays each of those elements accurately and consist-
ently.
Utility and Discussion
The SpliceCenter web-based application suite is designed
to assist biologists and bioinformaticists in analyzing the
impact of alternative splicing on studies of transcripts and
proteins. Each application identifies the target locations of
oligonucleotides or peptides within the unique splice var-
iants of the targeted gene or genes. Interactive investiga-
tion is supported through web-based applications that
return graphical results with clickable hyperlinks. High-
throughput applications for processing large query files
are implemented as batch applications that return text-
based result files. Currently support species are human,
mouse, and rat.
Primer-Check
Quantitative RT-PCR (qRT-PCR) is widely accepted as the
gold standard for validation of microarray expression
studies and is also widely used in its own right for accurate
measurement of mRNA levels. However, the process of
designing oligonucleotide primers for qRT-PCR requires
that all existing transcript variants be considered. For
example, if qRT-PCR primers and microarray probes target
different splice variants, validation of expression results
may be compromised. Primer-Check shows the splice var-
iants of a gene and indicates the target locations of PCR
primers specified by the user, thereby allowing rapid
determination of which variants are and are not targeted.
That information can help in the design or selection of
primers or in diagnosing unexpected results. The Primer-
Check application also includes the option to construct
graphical results that indicate the positions of both PCR
primers and microarray probes to evaluate whether the
two target the same variants. The user enters the target
gene and sequence of the oligonucleotides selected for use
as primers and/or detection probes. Primer-Check returns
a graphical display of the splice variants of the gene and
indicates the target locations of the primers (Figure 3).
Common usage scenarios include the following:
￿ Primer design and selection: Whether designing custom
primers or selecting commercial ones, it is important to
identify the splice variants that will be targeted. Primer-
Check can be used to ensure that selected primer pairs
hybridize to all variants (or specifically targeted variants)
and to screen for possible cross-hybridizations.
￿ Investigation of anomalous results: One potential rea-
son for failure of RT-PCR primers is that they are not tar-
geting the splice variant(s) present in the particular
sample being analyzed. Primer-Check is useful for trou-
ble-shooting RT-PCR primers that fail to provide the
expected amplification product.
￿ Validation of microarray data: As already noted, qRT-
PCR is considered to be the gold standard for validation
of microarray results. Primer-Check can display the target
locations of PCR primers and probes and the target loca-
tions of microarray probes in a single graphical display
that shows directly whether PCR primers and microarray
probes do, in fact, target the same variants.
The effect of splice variation on validation of microarray
expression data by qRT-PCR data is by no means hypo-
thetical. A study by Dallas and colleagues [17] found that
such correlations were negatively impacted by splice vari-
ation if PCR primers and microarray probes targeted dif-
ferently spliced transcripts. Figure 3 shows Primer-Check
results for SEC23IP (P125), a gene that showed discord-
ance between microarray and qRT-PCR results in the Dal-
las study [17]. Primer-Check identifies four known splice
forms of the gene. Two Affymetrix probe sets on the
U133A GeneChip target the RefSeq-annotated transcript
(NM_007190) that corresponds to SEC23IP. However,
one of those probes sets, 216392_s_at, also targets two
additional transcript variants (BC063800 and
AB019435), missing the fourth. The second probe set,
209175_at, targets only one of those additional variants
(BC063800), missing the other two. In contrast, the PCR
primers and probes from Applied Biosystems target all
four reported variants corresponding to SEC23IP, leading
to discordance between the qRT-PCR and microarray
results. Primer-Check can help diagnose or even avoid
such problems.
siRNA-Check
RNAi technologies based on exogenously administered
siRNAs or shRNAs are used extensively to investigate gene
function. For compactness in the following descriptions,
we will often use the term "siRNA" to include all of the
standard RNAi effector molecules. siRNAs mediate
sequence-specific gene silencing through targeted cleavageBMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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An overview of the data processing performed to determine the positions targeted by microarray probes, PCR primers, pep- tides, or siRNA/shRNAs and to retrieve/display the exon structures of splice variants Figure 2
An overview of the data processing performed to determine the positions targeted by microarray probes, 
PCR primers, peptides, or siRNA/shRNAs and to retrieve/display the exon structures of splice variants. The 
data processing flow in SpliceCenter is as follows: (1) SpliceMiner is used to pre-compute target positions for common com-
mercial microarray probes. Microarray probe sequence files are submitted to the batch query facility of SpliceMiner, and a 
results file then indicates the target of each probe in genomic coordinates. The results are loaded into the Probe Position and 
Microarray table of the mySQL database used by SpliceCenter. (2) EVDB data consisting of a list of the unique splice variants 
for each human gene are loaded into the SpliceCenter database. Genomic coordinates for each exon are specified by those 
data. (3) For analysis of RT-PCR, PrimerMatch searches a transcript sequence database to locate the primer target positions 
that correspond to the PCR primer sequences. PrimerMatch results indicate the target positions for PCR primers in transcript 
coordinates. (4) The Gene/Variant/Exon tables in the database are queried using the transcript coordinates of the PCR primer. 
The database results are used to convert PCR primer targets into genomic coordinates. (5) A complete list of the gene's splice 
variant exon positions and pre-computed microarray probe positions is retrieved from the database. (6) The genomic position 
information for splice variant exons, microarray probes, and PCR primers is passed to the ImageGenerator to construct the 
graphical image results.
Microarray Probe Sequence File
Pre-computed elements
PrimerMatch
Primer Position
PrimerMatch Hits
Transcript Sequence Database
Microarray Probe Positions
Variants and Exon Positions
SpliceMiner
SpliceCenter
SpliceMiner Probe assignment
>probe:HG_U95Av2:1138_at:395:301; Interrogation_Position=2631; 
Antisense; TGGCTCCTGCTGAGGTCCCCTTTCC
>probe:HG_U95Av2:1138_at:322:441; Interrogation_Position=2661; 
Antisense; GGCTGTGAATTCCTGTACATATTTC
>probe:HG_U95Av2:1138_at:213:419; Interrogation_Position=27-3; 
Probe_ID
1127_at354:297
1127_at:633:417
Gene
RPS6K
A1
Chro
m
1
Strand
+
+
Accession
NM_00295
3
Exon
25
25
Probe_Start (Chr)
26585007
26585019
Probe_Stop (Chr)
26585031
26585043
Variant
Symbol Accession
ACP1 NM_00430
ACP1 BC020699
Probe position
Array
1
1
Probe ID
1127_at:354:297
1127_at:633:417
Accession
NM_002953
NM_002953
Probe Start
26585007
26585019
Probe Stop
26585031
26585043
Exon
Exon
1
2
Accession
BC020699
BC020699
Start
254927
261866
Stop
255007
261939
Microarray
Name
Affymetrix U95A
Agilent Human 1A
ID
1
2
Gene
Chr
2
22
Symbol
ACP1
CHEK2
Strand
+
-
1
1..*
1..*
1..*
1
1
>NM_014332 
gttctcaataccgggagaggcacagagctatttcagccacagat
cgcagctcagaggacaccgggcgccccttccacctcc
>NM_013259
tgtgctgctattgtggatgccgcgcgtgtcttctcttctttcgggccc
Transcript
NM_0002953
NM_013259
Probe_Start
128
2234
Probe_Stop
158
2264
Primer
Primer_1
Primer_2
Chr
2
2
Chr_Start
268530
268650
Chr_Stop
268560
288680
User Probe 
sequence
EVDBBMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
Page 7 of 12
(page number not for citation purposes)
of a transcript via the RNA interference pathway. Selecting
an siRNA sequence that effectively targets a gene is a com-
plex task that requires in silico prediction of the ability of
the siRNA to mediate cleavage of the targeted transcript(s)
while avoiding partially homologous sequences of other
genes. Databases of experimentally-validated siRNAs and
several tools to aid in design are available [18,19]. To
achieve the goal of maximally silencing protein expres-
sion, it is safest to ensure that all protein-encoding tran-
script variants are targeted by the siRNA. Hence, in most
cases siRNAs have been designed to target all splice vari-
ants of a gene that are found in the RefSeq database. But
because RefSeq was not designed or intended to include
all known transcripts, non-RefSeq splice variants may not
be targeted. If, for example, an siRNA has been successful
in one cell type and then fails to silence expression in
another, the two cell types may be expressing different
splice variants. siRNA-Check can be used to confirm tar-
geting of all known variants or selective targeting of a par-
ticular variant (and, therefore, silencing of a particular
protein isoform). The following are typical uses of siRNA-
Check:
￿ Selection or design of siRNA (or shRNA) sequences:
Whether designing custom siRNAs or selecting commer-
cial ones, it is important to understand which variants will
be targeted. The siRNA-Check application can be used to
confirm targeting of all variants or selective targeting of a
particular variant (and, therefore, silencing of a particular
protein isoform). In interactive mode, the application
identifies siRNA target sequences within a gene via  an
intuitive graphical display. If an siRNA targets a sequence
that occurs in more than one gene, multiple graphics pan-
els, one for each gene, are displayed.
￿ Clarification of anomalous results: siRNA-Check pro-
vides a quick, easy way to investigate the possibility that
failure to silence a gene is due to splice variation. To cite
one example from our own work, when we were trying to
knock down expression of two apoptosis-associated
genes, BAD and YWHAZ, we observed differential expres-
sion of some of the untargeted transcript variants [3]. For
example, as shown in Additional Figure 1a [see Additional
file 2], two siRNAs that target BAD (siBAD.1 and siBAD.3)
mediated a significant decrease in mRNA levels when all
Graphical output of Primer-Check for SEC23IP (P125) showing the discrepancy between variants targeted by the Affymetrix  U133A array probe sets and Taqman (ABI) primer and probe sets [24] used by Dallas and co-workers [17] Figure 3
Graphical output of Primer-Check for SEC23IP (P125) showing the discrepancy between variants targeted by 
the Affymetrix U133A array probe sets and Taqman (ABI) primer and probe sets[24]used by Dallas and co-
workers[17]. Four distinct splice variants of SEC23IP are displayed. Orange vertical lines indicate the target positions of the 
microarray probes. Probe set 209175_at targets two of four variants, and probe set 216392_at targets three of four variants. 
The light blue vertical lines show the context sequence location for the qRT-PCR ABI Taqman primer/probe set that targets all 
splice variants. The dissimilarity of splice variant coverage between qRT-PCR primers and microarray probes creates the 
potential for discordant expression values, depending on which mix of variants is expressed in the sample being studied.BMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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variants of the gene were assayed (using the Branched
DNA-RNA Quantigene assay, Panomics, Fremont, CA).
But siBAD.2 produced no knockdown. Transcript-specific
qRT-PCR showed that NM_004322, the transcript variant
targeted by siBAD.2, represents only 1% of BAD mRNA
levels in the cell line studied. We saw analogous results for
the gene YWHAZ (Additional Figure 1b) [see Additional
file 2].
Array-Check
Transcript expression microarrays are being used as tools
throughout basic and clinical research. The results of
microarray expression studies are usually reported as lists
of over- or under-expressed genes. However, failure of the
oligonucleotide probes to detect all splice variants of the
target gene may confound interpretation of the results. For
example, a recent analysis of gene expression data
obtained for different microarray platforms showed that
genes exhibiting transcript variation had a lower signal
agreement between platforms than did genes with less
alternative splicing [20]. Array-Check enables the user to
see at a glance which variants are targeted by a given
microarray platform and, if desired, to compare the vari-
ants targeted by different microarray platforms (Figure 4).
Array-Check includes a database of pre-computed micro-
array probe target data for the most widely-used commer-
cial expression microarrays. The splice variant coverage of
a microarray should be taken into account in a variety of
research situations. The following are examples:
￿ Microarray platform evaluation: Figure 4 shows an
Array-Check comparison of Affymetrix 95A, U133A, and
U133 Plus 2 in their coverage of the ACP1 gene. Array-
Check thus provides a quick means of performing a side-
by-side comparison of the coverage of splice variants by
microarray platforms. It can be used in the mining of his-
torical microarray datasets to ensure that an older plat-
form provided good coverage of all variants of the gene of
interest. It may also be useful in selecting a platform for a
new study. As shown in the figure, the U133A and U133
Plus 2 Affymetrix arrays provide better coverage of the
ACP1 variants than does the U95A array.
￿ Microarray platform correlation: Comparison of expres-
sion values from different microarray platforms is prone
to misinterpretation if the platforms target different splice
variants. Array-Check provides a mechanism for compari-
son of probe target locations to identify potential splicing-
related differences. For example, Figure 4 shows that cor-
relation between probe set 36611_at on the U95A array
and probe set 1554808_at on the U133 Plus 2 array is
unlikely because those probe sets measure non-overlap-
ping subsets of the splice variants of ACP1.
￿ Trouble-shooting anomalous results: Alternative splic-
ing is a potential source of inconsistent expression meas-
urements among the probes in a nominal probe set.
Array-Check provides a rapid means for ascertaining the
known variants that are targeted or missed by probes on a
given microarray platform. Older microarrays were
designed before the availability of detailed annotation of
many of the recently-identified transcript variants. Array-
Check indicates splice variant coverage in the context of
up-to-date information on transcript variation.
Peptide-Check
Alternative splicing plays a critical role in higher organ-
isms by increasing the functional diversity of proteins. Iso-
forms that differ minimally in structure may perform very
different functions or may perform the same function in
different cell types or at different stages of development.
Failure to take splice variation into account can lead to
inaccurate or incorrect interpretation of experimental
results. Mass spectrometry and antibody-binding assays,
the most common technologies in proteomic research, are
susceptible to such problems. For those technologies,
Peptide-Check provides a simple interface that accepts
one or more short peptide sequences, generates a visuali-
zation of the known splice variants of the source gene, and
shows the location, within the mRNA transcript, of the
nucleotide sequence that codes for the peptide. Common
use-cases include the following:
￿ Design and analysis of peptide immunogens and anti-
gens: Peptide-Check has many applications in the context
of technologies that use antibodies or other ligands that
target peptide sequences. To cite one common example,
animals are often immunized with a peptide to generate
antibodies against a specific protein. Peptide-Check can
assist in selecting an immunizing peptide that occurs in all
splice forms of the protein or, conversely, in only one par-
ticular form. The latter type of specificity may be particu-
larly useful for identification of the biological or
pathological roles of individual protein isoforms. For
example, antibodies raised against peptides that represent
unique splice variants of p53 have helped to elucidate
details of the molecule's tumor suppressor function [21].
Peptide-Check provides a rapid method for identifying
the target variants of those p53 antibodies [see Additional
file 3]. It should be noted that Peptide-Check is capable of
processing only sequential peptide epitopes; it cannot
help with conformational epitopes that are composed of
multiple sequences within a protein.
￿ Analysis of Mass spectrometry results: Mass spectrome-
try is increasingly being used to identify and/or quantify
proteins in a biological sample after peptidolysis. The first
step is to identify peptides on the basis of mass/charge
ratios, partial sequences, and/or chromatographic elutionBMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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Graphical output of Array-Check showing the known splice variants of ACP1 and the positions of oligonucleotides used to tar- get the gene on (a) Affymetrix U95A, (b) Affymetrix U133A, and (c) Affymetrix U133 Plus 2 microarrays Figure 4
Graphical output of Array-Check showing the known splice variants of ACP1 and the positions of oligonucle-
otides used to target the gene on (a) Affymetrix U95A, (b) Affymetrix U133A, and (c) Affymetrix U133 Plus 2 
microarrays. The splice variants are identified by accession number. Green boxes, which indicate exons, are drawn to scale. 
Lighter green regions of the exons are UTRs, and dark green areas are the coding regions. Thin connecting lines, which indi-
cate introns, are not to scale. Orange vertical lines show the target locations of microarray probes. Probe lines intersecting 
exons indicate transcripts detected by the probe. Horizontal orange tie lines indicate splice junction probes (i.e., probes that 
cross exon boundaries).
a
c
bBMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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times. The identity of the original protein is then inferred
from the peptides by any of a number of available soft-
ware packages (reviewed in [22]). Peptide-Check can then
be queried to explain the presence or absence of peptides
that correspond to a given protein isoform and perhaps to
give information on which isoforms are expressed in the
sample. In principle, knowledge of splice variation could
also be included in calculation of the protein identifica-
tion probabilities provided by peptide fingerprinting pro-
grams.
Output of batch siRNA-Check used for high-throughput analysis of siRNA or shRNA libraries Figure 5
Output of batch siRNA-Check used for high-throughput analysis of siRNA or shRNA libraries. (a) The siRNA 
Position Report indicates the target location of each siRNA sequence, including gene symbol, chromosomal coordinates, and a 
link to a graphical view of the target gene. (b) The Hit/Miss report indicates which transcripts will, and which will not, be tar-
geted by each siRNA sequence. (c) Summary statistics from a batch siRNA-Check analysis of the unique shRNA sequences of a 
50,000+ shRNA library [23]. The chart indicates the percentage of shRNAs that do not target any currently annotated tran-
script, that target some but not all transcripts of the target gene, and that target all known splice variants of the target gene.
siRNA_ID Symbol Chr Strand Exon Chr_Start Chr_Stop Link
v2HS_100000 SIAE 11 - 12 124013710 124013692 http:// discover.nci.nih.gov /SpliceCenter/
siRNACheck?organism=9606&
symbol=SIAE&ID=v2HS_100000&
start=124013710&stop=124013692
v2HS_100002 HIST1H2BA 6 + 1 25835218 25835236
v2HS_100005 HIST1H2BA 6 + 1 25835493 25835511 http:// discover.nci.nih.gov /SpliceCenter/
siRNACheck?organism=9606&
symbol=HIST1H2BA&ID=v2HS_100005&
start=25835493&stop=25835511
v2HS_100014 ZNF398 7 + 9 148508224 148508242 http:// discover.nci.nih.gov /SpliceCenter/
siRNACheck?organism=9606&
symbol=ZNF398&ID=v2HS_100014&
start=148508224&stop=148508242
http:// discover.nci.nih.gov /SpliceCenter/
siRNACheck?organism=9606&
symbol=HIST1H2BA&ID=v2HS_100002&
start=25835218&stop=25835236
a
b
siRNA_ID Symbol Accession Hit_Miss
v2HS_100000 SIAE AF300796 H
v2HS_100000 SIAE AF303378 H
v2HS_100000 SIAE BC068450 H
v2HS_100000 SIAE NM_170601 H
v2HS_100000 SIAE BC040966 M
v2HS_100002 HIST1H2BA BC066238 H
v2HS_100002 HIST1H2BA BC066239 H
v2HS_100002 HIST1H2BA NM_170610 H
v2HS_100005 HIST1H2BA NM_170610 H
v2HS_100005 HIST1H2BA BC066238 M
v2HS_100005 HIST1H2BA BC066239 M
v2HS_100014 ZNF398 AB037760 H
v2HS_100014 ZNF398 AY049743 H
v2HS_100014 ZNF398 AY049744 H
v2HS_100014 ZNF398 BC043295 H
v2HS_100014 ZNF398 NM_020781 H
v2HS_100014 ZNF398 NM_170686 H
c
Hit all variants
Miss 1 or more variants
Miss all variants
9%
59% 32%BMC Bioinformatics 2008, 9:313 http://www.biomedcentral.com/1471-2105/9/313
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Batch Utilities
Each of the interactive SpliceCenter tools has a corre-
sponding batch application for high-throughput process-
ing of query files. For example, the batch form of siRNA-
Check accepts a FASTA-format file containing multiple
RNAi effector sequences (e.g. siRNA or shRNA). Two
result files are produced: 1) the Hit/Miss Report and 2) the
siRNA Position Report (Figures 5a and 5b). For each query
sequence, the Hit/Miss Report indicates the gene(s) tar-
geted by the siRNA sequence as well as the splice variants
that are, or are not, targeted. The siRNA Position Report
provides the genes, exons, and chromosomal coordinates
targeted by each query sequence. Batch siRNA-Check can
be used to evaluate large libraries of siRNAs or shRNAs.
The Hit/Miss report is useful for identifying those that fail
to silence all known variants of a gene or those that target
just a single transcript of interest. For detailed evaluation
of a specific entry, the Position Report provides a hyper-
link to an interactive-mode graphical representation of
the splice variants and positions of the siRNA sequences.
To illustrate the use of batch siRNA-Check, we processed
the publicly available sequences of a large-scale shRNA
library (constructed by Hannon and co-workers) available
as part of the Cancer Genome Anatomy Project (CGAP)
[23]. The reports produced by batch siRNA-Check identi-
fied the targets of each shRNA (Figure 5c). Of the 50,766
shRNAs in the library, 59% target all known splice vari-
ants of the target gene, 32% target some but not all tran-
scripts of the target gene, and 9% do not target any
currently annotated transcript.
Conclusion
Although alternative splicing is a ubiquitous and func-
tionally critical phenomenon in eukaryotic gene expres-
sion, fluent software tools have not been available to
assist researchers, particularly bench biologists, in deter-
mining which splice variants are targeted by particular
qRT-PCR primer sets, RNAi effectors, microarray plat-
forms or peptide-targeting reagents. Increasingly, all of
those methods are being used, separately or in combina-
tion, to analyze gene function. SpliceCenter's integrated
suite of applications for correlating experimental findings
with the transcriptional structure of a gene should signifi-
cantly aid in elucidating the roles played by splice varia-
tion in a wide range of biological processes and diseases.
The SpliceCenter applications, currently including
Primer-Check, Array-Check, siRNA-Check, and Peptide-
Check, provide user-friendly, web-based tools for the biol-
ogist and bioinformaticist.
Availability and requirements
The SpliceCenter website is available for use by academic,
government, or commercial users without restriction or
charge. The address of the site is: http://dis
cover.nci.nih.gov/splicecenter. We recommend using
Internet Explorer (version 6.0 or better) or FireFox (ver-
sion 2.0 or better) but are not aware of compatibility
issues with other browsers.
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